Viewing Study NCT04546633


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2025-12-31 @ 7:05 PM
Study NCT ID: NCT04546633
Status: COMPLETED
Last Update Posted: 2024-09-25
First Post: 2020-09-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-02-16
Start Date Type: ACTUAL
Primary Completion Date: 2024-08-13
Primary Completion Date Type: ACTUAL
Completion Date: 2024-08-28
Completion Date Type: ACTUAL
First Submit Date: 2020-09-05
First Submit QC Date: None
Study First Post Date: 2020-09-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-24
Last Update Post Date: 2024-09-25
Last Update Post Date Type: ACTUAL